Using multiparametric breast MRI data from three hospitals, the research team developed the MOME model to enable non-invasive malignancy classification, molecular subtyping, and neoadjuvant chemotherapy response prediction for personalized breast cancer m (IMAGE)

Hong Kong University of Science and Technology

Using multiparametric breast MRI data from three hospitals, the research team developed the MOME model to enable non-invasive malignancy classification, molecular subtyping, and neoadjuvant chemotherapy response prediction for personalized breast cancer m

Caption

Using multiparametric breast MRI data from three hospitals, the research team developed the MOME model to enable non-invasive malignancy classification, molecular subtyping, and neoadjuvant chemotherapy response prediction for personalized breast cancer management.

Credit

HKUST

Usage Restrictions

For news and media

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.